Introduction
Integrins are a family of transmembrane cell adhesion receptors that recognize cellsurface and extracellular matrix ligands 1 . All integrins are heterodimers composed of non-covalently linked alpha and beta subunits. In humans, at least 18 alpha and 8 beta subunits have been identified, forming more than 20 heterodimers, each of them with different cell expression patterns and ligand specificities 2 . Integrin-mediated interactions are vital to the maintenance of normal cell functioning, as they mediate the interaction between cells and with the extracellular matrix, having therefore important implications for cell adhesion, migration and proliferation. Integrins function as mediators for cell-cell interaction and adhesion, but may also elicit signal transduction events leading to cell activation and response to the extracellular stimulus 1 . Different enveloped and non-enveloped viruses utilize integrins to enter and replicate in host cells (reviewed in 3 ). Integrins may act as viral receptors which mediate virus attachment to the cell, a process which may also promote signalling responses influencing viral replication at a later step. In the case of human cytomegalovirus (HCMV), alphaVbeta3 has been described as an entry coreceptor, but also as a triggermediator of intracellular signalling pathways 4 . The alpha4beta7 integrin, preferentially expressed in activated T cells homing to the gut, may interact with the HIV-1 envelope glycoprotein gp120 leading to increased virus replication 5 .
Human blood monocytes, originated from haematopoietic precursors in the bone marrow, give rise to mature macrophages which are distributed ubiquitously in all tissues 6, 7 . Adhesion molecules, particularly integrins, have been shown to upregulate when monocytes differentiate into macrophages [8] [9] [10] , suggesting that integrins play an important role in macrophage adhesion, migration and tissue infiltration. Blood monocytes and tissue resident macrophages are important in vivo cell targets of HIV-1 only.
For personal use at PENN STATE UNIVERSITY on . bloodjournal.hematologylibrary.org From 4 infection [11] [12] [13] . Macrophages may become chronically infected or serve as reservoirs of latent virus. Furthermore, HIV may sequester macrophage immunoregulatory function, that is, inducing secretion of proinflammatory cytokines that lead to recruitment and activation of new target cells for HIV, including CD4+ T cells 14, 15 .
Unlike monocyte-derived macrophages (MDM), undifferentiated monocytes are not readily infected by HIV-1 in cell culture 16, 17 . A productive viral infection may only occur after monocytes are differentiated following serum or cytokine stimulation 18 , a process that leads to the upregulation of different cell-surface markers and receptors, including alphaV integrins 19, 20 and, more specifically, an increase in the vitronectin alphaVbeta3 receptor during the first 3-6 hour post-infection 14 .
We and others have shown the antiviral effect of specific anti-alphaV antibodies in MDM 19, 20 . Here, we describe the involvement of alphaV integrin mediated adhesion in HIV-1 replication of MDM and HeLa cells. Our data support the idea that blocking integrin alphaV interaction with its ligands initiates a signalling cascade that finally compromises HIV-1 replication by downregulating NF-κB dependent HIV-1 transcription.
only.
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Materials and Methods

Cells
HeLa-P4R5-MAGI (AIDS Reagent Program, National Institutes of Health, NIH, Bethesda, MD), containing a HIV-1 LTR driving expression of a lacZ reporter gene integrated into the genome, were cultured in Dulbecco's modified Eagle's medium (DMEM; Gibco, Madrid, Spain), supplemented with 10% heat-inactivated fetal calf serum (FCS; Lonza, Barcelona, Spain) and 1 μ g/ml puromycin (Sigma-Aldrich, Madrid, Spain).
Peripheral blood mononuclear cells (PBMC) were obtained from blood of healthy donors using a Ficoll-Paque density gradient centrifugation. To obtain the monocyte population, 300 million PMBC were blocked with an anti-CD32 antibody (StemCell Technologies, Vancouver, Canada) and monocytes were separated by a negative selection antibody cocktail (StemCell Technologies) supplemented with an anti-CD41 antibody (StemCell Technologies) to eliminate platelets. Cells from monocyte/macrophage lineage, identified by flow cytometry as CD14+, were obtained with a purity ≥ 85 %. Monocytes were resuspended in complete culture medium: RPMI 1640 medium (Gibco) supplemented with 10% heat-inactivated FCS, 100 U/ml penicillin, 100 μg/ml streptomycin and monocyte-colony stimulating factor (M-CSF; Peprotech, London, UK) at 20 U/ml (100 ng/ml). Then, monocytes were differentiated for 3 days at 50,000 cells/well in 96-well plates for viability and acute infection experiments. This study received IRB approval from the Scientific Research Committee of the Hospital Germans Trias i Pujol.
For the experiments under non-adhesive conditions, HeLa cells were maintained in sterile cryotubes rolling at 37ºC in culture media supplemented with HEPES buffer. Low adhesive conditions in MDM were achieved by plating in ultra low attachment plates (Corning Life Sciences, Schiphol-Rijk, The Netherlands).
Vitronectin (VN) (Sigma) coatings were performed at indicated concentrations on standard culture plates overnight at 4ºC, followed by intensive washes with PBS before monocyte plating.
Drugs
S36578
(5-(S)-7-{[4-(pyridin-2-ylamino)-butyrylamino]-methyl}-6,9-dihydro-5H-benzocyclohepten-5-yl) acetic acid (compound 1.2 synthesized as described by PerronSierra et al 21 ) is a selective small heterocyclic RGD-mimetic non peptide compound targeting alphaVbeta3 and alphaVbeta5 integrins 21, 22 . The RT inhibitor 3-azido-3-deoxythymidine (zidovudine; AZT) was purchased from Sigma-Aldrich, CCR5
antagonist TAK-779 (reviewed in 23 ) and AMD3100 were received from the NIH AIDS Reagent Program and the HIV integrase inhibitor L-731988 was obtained from Merck 24 .
Phorbol 12-myristate 13-acetate (PMA) was purchased from Sigma-Aldrich and tumor necrosis factor alpha (TNFalpha) from Peprotech.
Western blots and array hybridization
HeLa-P4R5-MAGI or MDM were harvested and lysed in chilled Cell Extraction Buffer (Invitrogen, Barcelona, Spain) supplemented with protease and phosphatase inhibitor cocktails (Sigma-Aldrich). Cell debris were removed by centrifugation, and the total cell homogenates were stored at -80°C until used for western blot or array hybridization.
Samples were run using Nu-PAGE 4-12% gels (Invitrogen) and blotted onto nitrocellulose membranes. Blocked membranes were incubated overnight with Invitrogen Mercator Phospho array kit (Biosource, Invitrogen) was used to determine phosphorylated amounts of the eight proteins included, following manufacturer's instructions. Data extracted from the scanned arrays were background-corrected as proposed in 25 .
Flow cytometry
Cells were detached with trypsin-free commercial EDTA/PBS solution (Versene; For quantitative analysis of viral DNA, DNA-extraction kit (Qiagen) was used.
Quantitative amplification of LTR for viral entry detection has been previously described 26 . Alu-LTR preamplification followed by the LTR quantitative amplification was performed to detect integrated HIV-1 27 . To normalize HIV copy values per cell, amplification of cellular RNaseP gene was performed (Applied Biosystems). DNA extracted from 8E5 cells (harboring one copy of integrated HIV-1) was used to build a standard curve.
Transfections
For siRNA treatment, 100 nM of siRNA were mixed with Lipofectamine 2000 reagent (Invitrogen) and 2x10 5 HeLa-P4R5-MAGI cells were seeded in 24-well plates in the absence of serum, using OPTIMEM medium (Invitrogen). After 24 hours, medium with serum was added and phenotype assessed 24 hours later.
siRNA custom sequence for siAlphaV#1 was AAGUUACUUCGGCUUCGCCGU, while siAlphaV#2, siBeta5 and siNon-targeting control were commercially available pools of four different siRNAs from Dharmacon.
For Tat-transactivation assays or NF-kappaB activation assays, plasmids (100 ng of pcTat 28 or 60 ng of pNF-kappaB/control-luciferase reporter (Clontech, Saint-Germainen-Laye, France)) were transfected into 1,5x10 5 pre-seeded HeLa-P4R5-MAGI cells 
Single-cycle infection assays
Similar to infections described above, cells were inoculated with viral stocks and 72 h later cells were concentrated and luciferase activity measured using the Bright-Glo luciferase assay system (Promega, Hospitalet, Spain) on a plate-reading luminometer (Fluoroskan Ascent FL, Labsystem).
Viability assays
For cell viability, MDM were treated with the same drugs at the same concentrations as for acute infection experiments. Measurement of cell cytotoxicity was performed by a methyl tetrazolium-based colorimetric assay (MTT method) as described before 19, 30 .
For HeLa-P4R5-MAGI cells, viability was estimated by counting total live cells by flow cytometry in the absence of viral infections. Fluorescent bead counts (Citognos, Salamanca, Spain) were used as reference for the samples' analysis. 
Results
AlphaV integrin function modulates HIV-1 infection in HeLa-P4R5-MAGI cells.
HIV-1 reporter HeLa cells are useful for the identification and study of cellular cofactors affecting HIV-1 replication 29, 31 . HeLa cells showed high levels of alphaV integrin and a partial expression of beta5 integrin as seen by flow cytometry ( Figure   1A ), while other beta integrin subunits known to be coupled with alphaV (beta3 and For Under these conditions, and contrary to the observations in S36578 or siRNA treatments, expression levels of cell surface receptors, including integrin alphaV, were decreased in both HeLa cells and MDM (Supplementary Figure 7) . However, these data suggest that alphaV-mediated attachment may be one of the cellular factors contributing to higher HIV-1 replication levels under adhesive conditions. Thus, blocking integrin mitogens, cytokines but also integrin-mediated stimuli 41 and, once activated, mediate several biological responses by phosphorylating a large number of substrates 38, 40 .
Previous reports suggested that PMA mediated activation of NF-kappaB and its subsequent induction of HIV transcription could be mediated by ERK1/2 MAPK 42 . In addition, alphaV inhibition by the racemate form of S36578 has been associated with changes in activation levels of ERK1/2 43 . Therefore, western blot analysis of HeLa and MDM treated or not with S36578 was performed. In agreement with published data, S36578 treatment of HeLa cells decreased the levels of ERK1/2 phosphorylation after treatment ( Figure 5A ). In the case of MDM, less pronounced decreased levels of ERK1/2 phosphorylation were observed at 24 hours post-treatment ( Figure 5A ). 
Discussion
The complex interactions between monocytes and macrophages and HIV-1 are of special importance, since these cells are relatively refractory to the cytophatic effects of HIV-1 and probably serve as major reservoirs for the virus and as a vehicle for disseminating HIV to various tissues [11] [12] [13] . Adhesion to the substrate and differentiation state enhances HIV replication in macrophages [35] [36] [37] . In addition, it has been shown that monocyte to macrophage differentiation process implies an upregulation of integrin expression 14, 20 . Here, we demonstrate that integrin alphaV is one of the mediators of this replication enhancement. Importantly, the impairment of integrin-mediated signalling, either by RNA inteference or using a small heterocyclic non-peptide RGD mimetic compound (S36578) selective for alphaVbeta3 and alphaVbeta5 integrins, disrupts such signalling pathways, compromising therefore HIV-1 replication.
Our results suggest that blocking integrin mediated adhesion would finally lead to an inhibition of HIV transcription mediated by NF-kappaB. These data are in accordance with previous results showing that HIV replication is induced by binding of the transcriptional activator NF-kappaB to the enhancer region of the viral LTR 36 . NFkappaB can be induced by several stimuli, including PMA and TNF-alpha 42 .
Interestingly, blocking alphaV-mediated attachment inhibits NF-kappaB activation when induced by PMA but not by TNF-alpha. It has been shown that, contrary to TNFonly.
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It is known that integrin-mediated cell adhesion causes activation and nuclear translocation of MAP-kinases 41, 44 . On the other hand, different signal transduction pathways involving calcium mobilization, PI-3K activation and downstream phosphorylation of MAP-kinases have been shown to control HIV transcription and post-transcription events 15 .Previous results 43 suggested a decreased phosphorylation of ERK1/2 MAP-kinase as a consequence of the blockade of integrin-mediated signalling.
Although this observation could explain on its own the inhibition of HIV-1 replication,
we also observed changes in the phosphorylation of p38-MAPK and its downstream phosphorylation target HSP27 45 . Interestingly, HSP27 phosphorylation has been linked to an inhibition of NF-kappaB activation 46 , suggesting that HSP27 could also play a role For
22
alphaV did not affect lymphocyte migration to lymphoid organs or in vitro activation of lymphocytes 47 . On the contrary, these models indicate an important role for alphaV integrin on myeloid cells (macrophages, dendritic cells, and/or neutrophils) in immune regulation 48 .
HIV infection is accompanied by a dramatic loss of CD4+ T cells predominantly from the mucosal surfaces. Macrophage phagocytosis of apoptotic cells is a process where alphaV is involved 48, 49 , a situation building a plausible scenario in which integrin activation could contribute to HIV infection and spreading. In fact, in vitro uptake of apoptotic cells by macrophages has been shown to enhance HIV replication 48, 49 .
Similarly, it would be of interest to explore the in vivo role of integrin alphaV in macrophage migration, attachment and infiltration to target tissues, processes where integrin activation could be contributing to HIV-1 dissemination and spread. Figure 5B Figure 5C only.
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